Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03730792 · ClinicalTrials.gov registry record · NA
Success & Health Impacts For Transit Drivers During Onboarding
A NA study of Obesity, sponsored by Oregon Health and Science University.
- Active
- Registry status
- NA
- Development phase
- 284
- Enrollment target
- 1
- Study location
NCT03730792: Active NA study of Obesity, sponsored by Oregon Health and Science University.
NCT03730792 is a NA study of Obesity that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 284 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03730792, a NA study of Obesity, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
- 1
- Study location
Study Summary
The project is a cluster randomized controlled trial of an occupational health intervention for newly hired bus operators. Transit authorities will be randomized to intervention and usual practice conditions and new bus operators will be recruited to participate in a two year study. Intervention participants will complete a program designed to prevent weight gain while also supporting early adjustment and job success. Control participants will experience standard or usual practice working conditions.
Primary Outcome
Directly measured body weight in kg.
Conditions Studied
Interventions
- BEHAVIORAL SHIFT Onboard Intervention
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2020-03-22 |
| Est. Completion | 2026-07 |
| Phase | NA |
What the registry record for NCT03730792 still lists
NCT03730792 is an interventional study that assigns participants to a tested intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which SHIFT Onboard Intervention is the first listed.
NCT03730792 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT03730792 about?
NCT03730792 is a clinical study titled "Success & Health Impacts For Transit Drivers During Onboarding". The project is a cluster randomized controlled trial of an occupational health intervention for newly hired bus operators. Transit authorities will be randomized to intervention and usual practice conditions and new bus operators will be recruited to participate in a two year study. Intervention par...
What is the current status of trial NCT03730792?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 284 participants. The study started on 2020-03-22. Estimated completion is 2026-07.
What conditions does trial NCT03730792 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT03730792?
The interventions under investigation include: SHIFT Onboard Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03730792?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03730792 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03730792's enrollment target sits among peer trials
284 238th of 1053 higher than 816 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- NCT06963034 · 284 participants · Phase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI